menu search

Medivir hosts expert perspectives webcast on the evolving treatment landscape and the unique treatment challenges in hcc

STOCKHOLM , Sept. 1, 2023 /PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments fo...

September 1, 2023, 3:20 am

23andme stock rallies more than 23% after genetics company gets ok to report more cancer risks

Shares of 23andMe Holding Co. ME, -4.35% jumped 23% in the extended session Thursday after the genetics and biopharmaceutical company said that the U....

August 31, 2023, 5:49 pm

Apollomics: a taiwanese-origin company with late stage pipeline

Apollomics is a small company with a pipeline of c-Met targeting small molecule TKIs for various cancers...

August 29, 2023, 6:21 am

Bridgebio pharma to present detailed results from the phase 3 attribute study in patients with transthyretin amyloidosis cardiomyopathy (attr-cm) at european society of cardiology (esc) congress 2023

PALO ALTO, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage...

August 24, 2023, 4:01 pm

Enliven therapeutics: preclinical company with interesting value proposition

Enliven Therapeutics, Inc. is a recently merged biopharma company focused on developing oncology candidates for leukemia and lymphoma. The company has...

August 18, 2023, 12:57 pm

Alpha tau announces robust long-term safety and efficacy data from multiple clinical trials of alpha dart

– 81 lesions treated across four feasibility trials of head and neck or skin cancers demonstrated 89%...

August 17, 2023, 9:00 pm

Where will exact sciences be in 5 years?

Exact Sciences has the potential to be a big name in cancer testing and screening in the future. It already has multiple tests, and is working on one ...

August 10, 2023, 9:37 am

Hillstream biopharma to present at the sidoti micro-cap virtual conference on august 16-17, 2023

BRIDGEWATER, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology compan...

August 9, 2023, 8:47 am

Plus therapeutics to announce second quarter 2023 financial results and host conference call on august 14, 2023

AUSTIN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company ...

August 8, 2023, 4:05 pm

Intensity therapeutics to announce financial results for the second quarter ended june 30, 2023, and provide corporate update

Webcast to be Held at 8:00 am ET on Monday, August 14, 2023 WESTPORT, Conn. , Aug. 7, 2023 /PRNewswire/ -- Intensity Therapeutics, Inc. (Intensity) (N...

August 7, 2023, 7:01 am

Plus therapeutics to present at the canaccord genuity 43rd annual growth conference

AUSTIN, Texas, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company ...

August 3, 2023, 7:00 am

Omega therapeutics: working in epigenetic anti-cancer programs

OMGA has an early stage program targeting various cancers using epigenetics. They are backed by a VC an...

August 1, 2023, 4:29 pm

Revolutin medicines to acquire eqrx in deal that will add $1 billion in cash to its balance sheet to fund r&d

Revolution Medicines Inc. RVMD, +2.10% said Tuesday it has reached a definitive agreement to acquire EQRx Inc. EQRX, in an all-cash deal that's expect...

August 1, 2023, 7:43 am

Bicycle therapeutics: decent upside opportunity, mid-stage data readouts due

Bicycle Therapeutics is an intriguing play in the drug development space. Using its fully synthetic short peptides, the company has developed two mid-...

July 31, 2023, 7:07 pm

Fda grants fast track designation to ivs-3001, a car-t cell therapy in the treatment of renal cell carcinoma

Houston, TX, USA, July 31, 2023 (GLOBE NEWSWIRE) — Invectys, Inc., a clinical-stage immuno-oncology company focused on developing novel therapies fo...

July 31, 2023, 10:00 am

Qualigen therapeutics divests fastpack® diagnostics business

All cash deal with Chembio Diagnostics, a US Subsidiary of the French Diagnostics Company BIOSYNEX, SA, solidifies Qualigen’s strategic priority on ...

July 24, 2023, 12:15 pm

Nanobiotix surges on commercialization deal with j&j's janssen for cancer therapeutic

French biotechnology company Nanobiotix has entered into an agreement with J&J's wholly-owned medical research and pharmaceutical arm Janssen to licen...

July 10, 2023, 1:11 pm

Genprex granted chinese patent for lead drug candidate reqorsa with pd-1 antibodies to treat cancers

Genprex Inc. revealed that the China National Intellectual Property Administration has granted it a broad patent, which covers the use of its lead dru...

July 5, 2023, 9:47 am

Black diamond therapeutics announces pricing of public offering of common stock

CAMBRIDGE, Mass and NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology ...

June 30, 2023, 12:57 am

Quest diagnostics' (dgx) new buyout expands cancer portfolio

Quest Diagnostics (DGX) will use MRD technology to create new blood-based clinical lab services for solid tumour ...

June 22, 2023, 2:06 pm


Search within

Pages Search Results: